Introduction
Prostate carcinoma (PCA) is diagnosed in American men more often than any other cancer, and ranks second only to lung cancer in terms of annual mortality (Parker et al., 1997) . Despite these sobering facts, relatively little is known about the mechanisms underlying PCA development and progression. While carcinomas of the breast and colon have undergone intense scrutiny in recent years, PCA remains in many ways a mystery. Some laboratories, including our own, have begun to analyse receptor tyrosine kinase (RTK) signaling pathways in prostate models, with the goal of better understanding the molecular features of PCA growth and development.
The epidermal growth factor receptor (EGFR) or ErbB family of RTKs is incompletely represented in human prostate tissue. Immunohistochemical studies have shown ErbB1/EGFR, ErbB2/NEU, and ErbB3 to be frequently co-expressed in both the normal prostate and in PCA (e.g. Myers et al., 1994; Prigent et al., 1992) . RT ± PCR has also been used to analyse benign prostatic hyperplasia (BPH), PCA tumor samples, lines, and xenografts for ErbB family transcripts. While ErbB1, ErbB2 and ErbB3 were all consistently observed, ErbB4 was never detected (Robinson et al., 1996; Wainstein et al., 1994) . ErbB3 Tzahar et al., 1994) and ErbB4 (Plowman et al., 1993a,b) have been identi®ed as receptors for the Neu Dierentiation Factors (NDFs), or heregulins, a family of alternatively spliced polypeptide ligands (Holmes et al., 1992; Peles et al., 1992; Wen et al., 1992) . This group of ligands includes the acetylcholine receptor inducing activity (ARIA) at the neuromuscular junction (Falls et al., 1993) and glial growth factor (GGF)/neuregulin in neurons and Schwann cells (Marchionni et al., 1993) . Since ErbB4 has not been observed in human PCA nor in immortalized prostate lines, ErbB3 appears to be the only NDF receptor in these tissues.
ErbB3 diers from other ErbB family members in that it possesses diminished kinase activity . Alternatively, some investigators have detected ErbB3 autophosphorylation in vitro (Kraus et al., 1993) . However, it appears that ErbB3 is largely dependent upon other ErbB kinases, in particular ErbB2/NEU, to trans-phosphorylate and activate it following NDF binding (Alimandi et al., 1995; Beerli et al., 1995; Carraway and Cantley, 1994; Gamett et al., 1995; Sliwkowski et al., 1994; Wallasch et al., 1995) . Another salient feature of ErbB3 is its C-terminal tail, which is substantially longer and more divergent in sequence than the analogous regions of other family members (Kraus et al., 1989; Plowman et al., 1990) . This cytoplasmic region bears many potential docking sites for src homology-2 (SH2) domain-containing proteins, which bind to phosphotyrosine residues in a speci®c sequence context (Zhou et al., 1993) . Putative binding sites exist for the p85 subunit of phosphatidylinositol 3-kinase (PI3-K), the adaptor proteins SHC and GRB2, the src family tyrosine kinases, and the SHP-2/Syp tyrosine phosphatase. Thus far, only PI3-K (Carraway et al., 1995; Fedi et al., 1994; Gamett et al., 1995; Kim et al., 1994) and SHC (Prigent and Gullick, 1994; Wallasch et al., 1995) have been shown to associate with ErbB3 in vivo.
NDF signal transduction pathways have been studied in breast (Bacus et al., 1996; Marte et al., 1995a; Sepp-Lorenzino et al., 1996) , ®broblast (Carraway et al., 1995; Zhang et al., 1996) , hematopoietic (Pinkas-Kramarski et al., 1996; Riese et al., 1995) and chinese hamster ovary (CHO) cells . Activation of PI3-K, p70 ribosomal S6 kinase (p70 S6K ), extracellular signalregulated protein kinase (ERK) and the stressactivated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) have been observed in these various systems. The downstream physiological eects of NDF are highly cell-type dependent. Studies of breast lines have exempli®ed such divergent responses. While NDF treatment elicited mitogenesis in the T47D transformed line and HC11 mammary epithelial cells (Marte et al., 1995a) , it caused growth arrest and dierentiation in the AU565 line .
In this report, we analysed ErbB receptor and ligand expression in human prostate lines and a xenograft. Each system examined showed a dierent pattern of ErbB receptor expression. NDF protein was observed only in MLC-SV40, a non-transformed prostate epithelial line . Treatment of the LNCaP line with recombinant human NDF resulted in crosstalk between ErbB3 and ErbB2, but did not involve ErbB1/EGFR. NDF failed to turn on several pathways usually linked to ErbB1 activity, namely those of PLCg and of STATs 1, 3 and 5. The pathways of mHOG/p38, ERK/MAPK, and JNK/SAPK were all activated to varying degrees. PI3-K was engaged by ErbB3, but downstream activation of p70 S6K did not occur. Finally, long-term incubation of LNCaP with NDF altered cell morphology and inhibited growth, in direct contrast to the growth-promoting eects of transforming growth factor-alpha (TGF-a).
Results

Expression of ErbB kinases and their ligands in PCA
In the present study, we investigated signaling by the ErbB family of receptor tyrosine kinases, which heterodimerize extensively. The relative abundance of dimerization partners within a given cell type is likely to in¯uence both the nature and the intensity of growth factor-induced signals. Thus, it was initially essential to determine the relative protein expression levels of these kinases in our model systems. Western blots were performed on whole-cell lysates with antibodies against the ErbB family receptors, or against actin, as a loading control. As depicted in Figure 1 , each prostate line or xenograft exhibited a distinct pattern of ErbB kinase expression. LNCaP displayed the highest ErbB3 expression of the four passageable lines examined, while the CWR22 xenograft demonstrated the highest overall ErbB3 levels. Notably, both LNCaP and CWR22 are androgen receptor positive (AR+) systems. In addition, LNCaP showed a relatively high level of ErbB2 expression. ErbB2 has been shown to play an important role in signaling from the kinaseimpaired ErbB3. For these reasons, LNCaP was chosen for our further studies of NDF signals. RT ± PCR demonstrated that ErbB4 was not expressed by any prostate line examined (data not shown), in accordance with previously published results (Robinson et al., 1996) .
The four lines and the xenograft were also analysed for their expression of the ErbB3 ligand NDF/ heregulin, and of the ErbB1 ligands TGF-a and EGF, as shown in Figure 2 . For NDF, whole cell lysates were immunoblotted with anti-NDF antibody, while RT ± PCR was used to analyse TGF-a and EGF transcript expression. Interestingly, we found p44 NDF expressed only in the immortalized, non-transformed MLC-SV40 line. TGF-a was expressed in all lines
-
WB: α-actin Figure 1 ErbB family kinase expression in human PCA cell lines and a xenograft. DU145 (D), LNCaP (L), MLC-SV40 (M), PC-3 (P) and CWR22 (C) were harvested at 70 ± 80% con¯uency during normal serum growth conditions. For Western blots, cells were lysed in RIPA buer: 50 mM Tris-Cl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 1 mM PMSF, 1 mg/mL pepstatin A, 0.2 U/mL aprotinin and 0.5 mg/mL leupeptin. After protein quantitation of lysates, 50 mg total cell protein was loaded per well of a 7.5% gel, subjected to SDS ± PAGE, and transferred to PVDF membranes. Byrne et al., 1996) . By contrast, NDF is expressed only in a normal prostate epithelial line, suggesting its possible role in dierentiation. Described below are our studies of NDF signals in LNCaP cells.
The overall tyrosine phosphorylation pattern induced by NDF
Tyrosine phosphorylation is utilized by cells to signal growth and other responses. Whole-cell lysates of serum-starved LNCaP, either untreated or treated with NDF-b1, were immunoblotted with anti-phosphotyrosine antibody. As indicated by asterisks in Figure 3 , proteins of the approximate molecular weights 42, 46, 52, 66, 85, 92, 96, 105 ± 130 (smear) and 185 kDa were tyrosine phosphorylated in response to NDF. Some of these bands correspond to ErbB receptors and to other known signaling proteins, as will be demonstrated below.
The activation of ErbB family kinases
NDF has been shown to bind directly to ErbB3 and ErbB4. The eect of ligand binding, however, can be propagated through ErbB2 and ErbB1 via heterodimerization, leading to pairs such as ErbB3/ErbB2, Figure 2 The ErbB3 ligand p44 NDF is expressed only by a non-transformed prostate line, MLC-SV40. Lane labels are as in Figure  1 . Whole cell lysates were Western blotted with anti-NDF polyclonal antibody (NeoMarkers) and developed by ECL. RNA was extracted with Tri-Reagent (GibcoBRL), treated with RNAse-free DNAse (Boehringer Mannheim), reverse transcribed with AMV Reverse Transcriptase, and subjected to 30 cycles of PCR with oligonucleotide primers speci®c for human TGF-a, EGF, or GADPH. PCR products were resolved on a 2% agarose/ethidium bromide gel, and visualized by u.v. Molecular weights are in kilodaltons for the Western blot, and in base pairs for the RT ± PCRs Figure 3 Overall tyrosine phosphorylation pattern and ErbB kinase crosstalk in NDF-treated LNCaP. Cells were serumstarved overnight, unstimulated (7) or stimulated with 128 ng/ mL NDFb-1 (+) for 10 min at 378C, and harvested in RIPA buer. RIPA lysates containing 2 mg total cell protein were used for each immunoprecipitation, using antibodies for ErbB3, ErbB2 and ErbB1. IPs and 50 mg whole cell lysates from untreated and treated cells were subjected to SDS ± PAGE and Western blotting with anti-phosphotyrosine (mAb 4G10, UBI). Blots were developed by ECL. Asterisks (*) indicate proteins which underwent tyrosine phosphorylation after NDF treatment of LNCaP ErbB3/ErbB1 and so forth. In this way, the signals are diversi®ed. Since ErbB3 is kinase-impaired, heterodimerization is viewed to be crucial to its activity. Thus, our ®rst task was to de®ne the NDF activation pro®le of ErbB kinases in LNCaP. Since ErbB4 is not generally expressed in PCA, we have concentrated on the activation of ErbB3 and its accompanying ErbB2 and ErbB1 receptors by NDF. After NDF treatment, cell extracts were immunoprecipitated with antibodies directed against ErbB3, ErbB2 or ErbB1, followed by Western-blotting with anti-phosphotyrosine antibody (a-PY). As shown in Figure 3 , the tyrosine phosphorylation level of ErbB3 was signi®cantly increased, as was that of ErbB2. In contrast, a slight decrease in ErbB1 tyrosine phosphorylation was observed. Thus, under the conditions tested, NDF induces primarily ErbB3/ErbB2 heterodimer formation, with little or no involvement of ErbB1.
The speci®c signal transduction pathways
Based upon the sequence contexts of phosphorylatable tyrosine residues in the cytoplasmic domains of ErbB3 and ErbB2, a number of SH2-containing signaling molecules are postulated to associate with these kinases following activation. In practice, however, the signals emitted by receptors can vary signi®cantly from those predicted by theory, and can only be determined empirically. We have therefore undertaken a systematic analysis of the signaling pathways engaged by activated ErbB3 and ErbB2 in PCA models.
ERK, mHOG/p38 and JNK/SAPK are activated
The prototype mitogen-activated protein kinase (MAPK) pathway in mammals is the transmission of signals from SHC/GRB2 via ras/raf/MEK to the extracellular signal-regulated kinase (ERK) isoforms p44 ERK1 and p42
ERK2
. The activation of this pathway is characterized, among other features, by tyrosine phosphorylation of SHC and ERK. Figure 4a shows that both SHC and ERK were phosphorylated on tyrosine after NDF treatment, indicating activation of this pathway. In parallel, two other mammalian MAPK pathways have been demonstrated. They are de®ned respectively by two kinases sharing homology with ERK: mHOG/p38 (Galcheva-Gargova et al., 1994; Han et al., 1994) , and the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK; Derijard et al., 1994; Kyriakis et al, 1994) . Activation of mHOG was measured by its tyrosine phosphorylation, while JNK activation was analysed by its ability to phosphorylate the exogenous substrate GST-Jun. As shown in the phosphotyrosine blot of anti-mHOG immunoprecipitates, mHOG is activated by NDF. The kinase activity of JNK towards GST-Jun was weakly enhanced by NDF stimulation (Figure 4b ). This activation was less than that elicited by TGF-a, and considerably less than that induced by anisomycin or sorbitol. While mHOG is usually associated with stress responses, it has also been shown to be involved in the regulation of dierentiation and apoptosis (Wang and Ron, 1996; Xia et al., 1995) . Thus, the involvement of mHOG in NDF signaling may play a role in the ligand's ability to induce dierentiation in certain cell types. To our knowledge, this is the ®rst report demonstrating activation of the mHOG/p38 pathway by NDF.
PLC-g1 is not activated
In addition to MAPK pathways, the phospholipase Cg (PLCg)/Protein Kinase C (PKC) cascade can be activated by receptor tyrosine kinases such as ErbB1 Nishibe et al., 1990; Wahl et al., 1990) . As shown in Figure 5 , PLC-g1 was not tyrosine phosphorylated after NDF treatment of LNCaP. This result contrasts with the strong tyrosine phosphorylation of PLC-g1 observed following TGF-a stimulation.
PI3-K is assembled into an activation complex
Phosphatidylinositol 3-kinase (PI3-K) is a heterodimeric lipid kinase, consisting of a 110 kDa catalytic subunit and an 85 kDa regulatory subunit. The former catalyzes the addition of phosphate to the D-3 position of membrane-localized phosphoinositides, while the latter mediates translocation to the plasma mem- and p42 ERK2 ; and the mHOG/p38 MAP kinase. The position of an unidenti®ed p50 species is also indicated. (b) The JNK pathway is weakly stimulated. 2 mg lysates from untreated LNCaP (7), or from LNCaP treated with 128 ng/mL NDF (N), 25 ng/mL TGF-a (T), 10 mg/mL anisomycin (A), or 0.4 M sorbitol (S) were immunoprecipitated with polyclonal anti-JNK (Santa Cruz). The JNK IPs were subjected to an in vitro kinase assay using bacterially-expressed GST-Jun as a substrate, run on a 10% SDS-polyacrylamide gel, and dried. Autoradiography was performed with an intensifying screen at 7708C brane, where lipid substrate is located (reviewed in Kapeller and Cantley, 1994) . The p85 subunit contains two SH2 domains, which bind phosphotyrosine residues in the cytoplasmic domains of receptor tyrosine kinases. The consensus p85 binding site, YXXM (Zhou et al., 1993) , is repeated seven times in the C-terminal region of ErbB3, suggesting an important role for PI3-K in ErbB3 signaling. While p85 itself can be tyrosine phosphorylated, this phosphorylation is not considered as critical for activation as membrane translocation (Klippel et al., 1996) .
In LNCaP without NDF treatment, p85 was minimally phosphorylated on tyrosine, as revealed by anti-PY Western blotting (Figure 6a , top panel). Upon NDF treatment of LNCaP, tyrosine phosphorylation of p85 was increased. More remarkably, however, PI3-K had formed an`activation complex' with several other tyrosine-phosphorylated proteins, with the observed sizes of 185, 120 ± 100 (smear), 66 and 52 kDa. It is also possible that these associated species could have formed dimeric complexes with p85, instead of a large, multi-protein assembly. Immunoblotting of PI3-K immunoprecipitates with anti-ErbB3 con®rmed that the 185 kDa band contained ErbB3 (Figure 6a , bottom panel). The 52 kDa/66 kDa bands correspond to the sizes of p52 SHC and p66 SHC . The identities of the 120 ± 100 kDa species are unknown. For additional evidence of an ErbB3/PI3-K interaction, ErbB kinase immunoprecipitates were blotted with anti-p85. As shown in Figure 6b , p85 was observed to associate only with ErbB3 following NDF treatment, but not with the other family members. While ErbB3 most likely formed heterodimers with ErbB2, p85 was not co-immunoprecipitated with ErbB2. This probably occurred because the ErbB2-p85 association was indirect, and weaker than the direct ErbB3-p85 binding. Thus, NDF signi®cantly induces the association of PI3-K with ErbB3, along with additional components of the receptor complex.
The p70 ribosomal S6 kinase (p70 S6K ) has been placed downstream of Akt in the PI3-K pathway (Burgering and Coer, 1995; Franke et al., 1995) . Some signaling proteins, such as p70 S6K , are activated by phosphorylation on serine and/or threonine rather than on tyrosine. A mobility shift induced by ligand stimulation can be interpreted as phosphorylation, and hence, activation (Blenis et al., 1991) . Immunoprecipitates of p70 S6K from NDF-treated LNCaP were blotted with anti-p70 S6K antibody. However, as depicted in Figure 6c , p70 S6K was not observed to undergo any shift. An in vitro kinase assay of p70 S6K immunoprecipitates also failed to reveal activation (data not shown). Thus, despite the strong activation of PI3-K in LNCaP, p70 S6K is not turned on (see Discussion).
STATs 1, 3 and 5 are not activated
The signal transducers and activators of transcription (STATs) are a family of latent cytosolic transcription factors which are activated by tyrosine phosphorylation (Darnell et al., 1994; Ihle et al., 1994) . Activation has been shown to stem from either the JAK/Tyk family of non-receptor tyrosine kinases in association with interferon receptors, or by RTKs such as ErbB1 (Fu and Zhang, 1993; Ru-Jamison et al., 1993; Sadowski et al., 1993; Silvennoinen et al., 1993) . Subsequently, the STATs dimerize and translocate to the nucleus where they direct transcription from speci®c genetic sequences. Their sequence-speci®c binding is exploited by the electrophoretic mobility shift assay (EMSA) to determine STAT activation.
Neither the sis-inducible element (SIE) probe for STATs 1 and 3 (Figure 7a ), nor the b-casein promoter element probe for STAT5 (Figure 7b ), demonstrated a gel shift in response to NDF treatment of LNCaP. In fact, all of the prostate lines and the xenograft used in this study tested negative for NDF-induced activation of STATs 1, 3 or 5 (data not shown). LNCaP treated with TGF-a did not reveal STAT activation (data not shown). On the other hand, STATs could be activated in another prostate line, MLC-SV40, which was therefore used as a positive control. MLC-SV40 stimulated with TGF-a exhibited binding activity to both probes. The SIF-B and SIF-C complexes were shown to contain STAT1 by antibody supershifting. The absence of STAT binding activity in NDF-treated LNCaP thus cannot be attributed to the assays used, or to a lack of STAT expression, since both STAT1 and STAT3 proteins were detected by Western blotting their respective IPs (data not shown).
NDF alters growth properties and morphology of LNCaP
Signal transduction pathways ultimately subserve whole cell physiology, including the processes of growth, attachment, migration, dierentiation, and apoptosis. Previously, others have shown NDF to have mitogenic, dierentiative, or survival-promoting eects, depending upon the system examined. We wished to test NDF for its eects on LNCaP proliferation. After being plated out at low density (2610 5 cells/100 mm dish) and allowed to attach for 24 h, triplicate dishes of LNCaP were treated for 6 days with NDFb-1 or TGF-a in serum-containing medium, or with serum-containing medium alone. Figure 8a illustrates the inhibition of LNCaP growth by long-term NDF stimulation. This experiment was performed in the standard growth medium for LNCaP, which contains 10% fetal bovine serum. The maximal PLCg-1 is not tyrosine phosphorylated following NDF treatment, while it is after TGF-a stimulation. Serum-starved LNCaP were either untreated (7), or treated with 128 ng/mL NDF (N) or 25 ng/mL TGF-a (T). 2 mg cellular lysates were immunoprecipitated with anti-PLCg-1 antibody (UBI). The IPs were run on 7.5% SDS ± PAGE and Western blotted with anti-PY. The location of the 148 kilodalton PLCg-1 is indicated observed eect was a 49% decrease in LNCaP cell number at day 4, when compared with untreated controls. This was in direct contrast to TGF-a treatment, which elicited a 43% increase in cell number over normal serum conditions at day 4. After NDF treatment, we did not observe a greater number of trypan blue-staining cells, or cells¯oating in the media. Thus, while they cannot be completely ruled out, cytotoxicity or apoptosis are unlikely explanations for the reduced cell number. Concurrent with its apparent restriction of cell growth, NDF also induced a marked alteration in LNCaP morphology. Phase-contrast microscopy was used to document this change, as shown in Figure 8b . Despite its epithelial origin, LNCaP normally possesses a spindle-shaped morphology with interdigitating processes. Strikingly, NDF-treated cells exhibited greater aggregation and membrane contact than did untreated controls, along with a withdrawal of cytoplasmic processes. The above results, taken together, suggest that NDF exerts an antiproliferative eect on LNCaP. Furthermore, this eect is dominant, since it can partially overcome the strong growth signals induced by serum.
Discussion
Each human PCA line examined displayed a distinct pattern of ErbB1, ErbB2, and ErbB3 expression. In accordance with previous ®ndings, ErbB4 was not observed in any system examined. The greatest variation in receptor expression was seen for ErbB1, the receptor for TGF-a and other EGF ligands, and for ErbB3, the sole NDF receptor in PCA. While DU145 and MLC-SV40 showed high expression of ErbB1, LNCaP exhibited low ErbB1 levels. On the contrary, LNCaP showed high expression of ErbB3, while DU145 and MLC-SV40 displayed considerably lower ErbB3 levels. It is likely that relative ErbB family We observed expression of NDF only in MLC-SV40, a non-transformed prostate epithelial line. Our results are consistent with the data of others, which showed that NDF immunostaining is more frequent in benign prostate epithelium than in PCA (Lyne et al., 1997) . These combined ®ndings suggest that NDF signals may contribute to the growth restriction and/or dierentiation of prostate epithelia. In resonance with this hypothesis, we showed here that NDF treatment of LNCaP inhibits its growth and induces morphological changes consistent with a more dierentiated phenotype. This response is in stark contrast to that observed following TGF-a treatment, which primarily induces growth of this cell type. A conclusive demonstration of NDF-induced dierentiation would require the detection of dierentiation-speci®c antigens after NDF treatment.
As summarized in Figure 9 , our comprehensive analysis of NDF-induced signals in LNCaP revealed that ErbB2 and ErbB3, but not ErbB1, are engaged in transmitting these signals. In fact, ErbB1 was seen to reduce its phosphotyrosine content after NDF treatment. We interpret this ®nding to mean that ErbB2/ After incubation of nuclear lysates with probes for 30 min at 308C, mixtures were subjected to nondenaturing PAGE on 0.256TBE/5% polyacrylamide gels. Gels were dried and exposed to ®lm at 7808C ErbB3 heterodimer formation removes ErbB2 from preexisting ErbB1/ErbB2 heterodimers, leaving ErbB1 in the inactive state. Our ®nding also supports a preferred ErbB3/ErbB2 pairing to that of ErbB3/ ErbB1 in LNCaP cells upon NDF treatment.
The multiple parallel MAPK pathways can be dierentially regulated in order to elicit varying cellular responses. When LNCaP was stimulated with NDF, the ERK MAP kinase, mHOG/p38 and JNK/ SAPK were all activated, albeit to dierent extents. This dierential activation may play a role in the growth-inhibitory response of LNCaP to NDF. Particularly intriguing is the activation of mHOG. While originally identi®ed as a mediator of stress and in¯ammatory responses, mHOG is also likely to play a role in dierentiation (Wang and Ron, 1996) . Thymocyte dierentiation has been shown to correlate with mHOG activity (Sen et al., 1996) . Of additional interest, the overexpression of mHOG has been shown to inhibit mitogen-stimulated cyclin D1 expression (Lavoie et al., 1996) . Thus, activation of the mHOG pathway may help steer a cell away from proliferation and towards dierentiation.
The p85 regulatory subunit of PI3-K binds to phosphotyrosine in the consensus YXXM motif via its pair of SH2 domains (Kapeller and Cantley, 1994) . In the ErbB kinase family, the NDF receptors ErbB3 and ErbB4 possess such p85 binding sites. Since ErbB4 is not expressed in any prostate system examined, ErbB3 is theoretically the only member of the ErbB kinase family in PCA which can bind directly to p85. Indeed, ErbB3 and other tyrosine-phosphorylated species assembled into a striking`activation complex' with PI3-K following NDF treatment. Alternatively, these proteins may represent dimeric partners of p85. The associated signaling proteins are likely to include p52 SHC and p66 SHC , in addition to other as-yet unidenti®ed species. Since only in the PI3-K immunoprecipitation was such a complex detected, we presume the concentration of activated PI3-K is limiting, and that it is stoichiometrically assembled with ErbB3. Other signaling molecules such as SHC could then attach to this complex.
In addition, the p85 subunit of PI3-K associated with ErbB3 in an NDF-dependent manner, but not with ErbB1 or ErbB2. Thus, ErbB3 occupies a position which is likely to be critical in PI3-K-modulated growth pathways. While PI3-K has been linked primarily to mitogenic responses, it is also involved in dierentiation of certain cell types. For example, the dierentiation of PC12 cells in response to nerve growth factor (NGF), and Leydig tumor cells in response to EGF, has been shown to involve PI3-K (Ohmichi et al., 1992; Pignataro and Ascoli, 1990; Solto et al., 1992) . Skeletal muscle, hematopoietic, and adipocytic dierentiation have also shown dependency on PI3-K (Kaliman et al., 1996; Kitanaka et al., 1996; Kubota et al., 1996; Tomiyama et al., 1995) . By analogy, it is also possible that ErbB3-mediated PI3-K activation could play a role in PCA cell dierentiation. Initially to our surprise, we found that p70 S6K , a kinase located downstream of PI3-K (Cheatham et al., 1994; Chung et al., 1994) , was not activated by NDF treatment of LNCaP. It is conceivable that, in LNCaP, a phosphatase for p70 5 cells were plated out per 100 mm dish in RPMI 1640+10% fetal bovine serum (FBS, GibcoBRL). After 24 h, cell dishes were switched to complete medium (RMPI 1640+10% FBS; squares), complete medium+12.8 ng/mL NDFb-1 (triangles), or complete medium+2.5 ng/mL TGF-a (diamonds). Media was changed every 2 days thereafter, except for the cells being counted. Viable cells in triplicate dishes were counted by trypsinization and trypan blue staining in a hemocytometer. Standard deviations are indicated by error bars. This experiment was performed twice. (b) LNCaP displays morphological changes in response to NDF treatment. Phase-contrast microscopy was performed at day 3 of the experiment in part (a). Cells exhibited retraction of processes, a more polygonal shape, and greater membrane contact between adjacent cells. Also, they showed a tendency to form monolayer aggregates. Representative ®elds are shown. Magni®cation=2006 S6K activity may not always be necessary for the physiological eects of NDF, since several recent reports have shown p70 S6K to be dispensable for PI3-K-mediated suppression of apoptosis (Dudek et al., 1997; Kaumann-Zeh et al., 1997; Kulik et al., 1997; Yao and Cooper, 1996) , glycogen synthesis (Welsh et al., 1994; Yamamoto-Honda et al., 1995) , and gene expression (Sutherland et al., 1995) .
Both the STAT and PLCg pathways can be activated by TGF-a treatment in prostate lines. Yet, they are unaected by NDF stimulation. Most likely, these cascades are not engaged because ErbB1 is not involved in NDF signal transduction in PCA.
When NDF/heregulin was cloned , it was characterized by its ability to induce growth arrest and dierentiation of AU565 human breast cancer cells . NDF also elicited a dierentiated phenotype in the MCF-7 breast cancer line (Beerli et al., 1995) . Evidence supporting a growth inhibitory and/or dierentiative function of NDF has also been gleaned from studies of neural crest stem cells, which slowed their proliferation and differentiated into glia following NDF treatment (Shah et al., 1994) . Also, mammalian and avian myotubes responded to NDF/ARIA by expressing the acetylcholine receptor, a marker of dierentiation (Chu et al., 1995; Falls et al., 1993; Jo et al., 1995) .
Alternatively, the study of some cell types revealed an anti-apoptotic or survival response. NDF was seen to prevent the apoptosis of Schwann cells following neonatal muscle denervation (Trachtenberg and Thompson, 1996) . In IL-3 dependent hematopoietic lines transfected with various combinations of ErbB receptors, NDF could promote survival or proliferation, depending upon the receptor complement (Pinkas-Kramarski et al., 1996; Riese et al., 1995) .
Finally, NDF induces a mitogenic response in numerous cell types, including ®broblasts (Carraway et al., 1995) , certain breast cancer lines and mammary epithelial cells (Beerli et al., 1995; Marte et al., 1995a,b; Ram et al., 1995) , keratinocytes (Marikovsky et al., 1995) , and CHO cells . Fibroblasts also underwent transformation in the presence of NDF (Wallasch et al., 1995; Zhang et al., 1996) .
Clearly, NDF has the ability to in¯uence numerous biological processes, and does so in a cell typedependent manner. A given cell's complement of ErbB family receptors will aect downstream signaling. While these signals can appear identical in dierent cell lines, they do not always result in the same physiological response. For example, NDF induced activation of MAPK and p70 S6K in both the T47D and AU565 breast cancer lines. However, T47D responded by proliferating, while AU565 dierentiated. Parameters other than receptor expression are also likely to aect the outcome of NDF stimulation, including hormone receptor and transcription factor expression.
To our knowledge, this is the ®rst report to characterize NDF-mediated signal transduction in prostate cells. We present evidence for activation of multiple pathways, the pattern of which is dierent for that of TGF-a. These data provide essential baseline information for the subsequent elucidation of signaling pathways involved in the growth and dierentiation of prostate carcinoma. In addition, we observed growth inhibition of LNCaP following long-term NDF treatment, accompanied by morphological changes such as cell clustering, withdrawal of processes, and increased cell ± cell membrane contact. These alterations are consistent with the reversion to an epithelial phenotype (Owens et al., 1976) . In order to test this possibility, NDF-stimulated LNCaP will be analysed for increased expression of epithelial-speci®c markers. Future research will also attempt to identify which of the signaling molecules activated by NDF are essential for its physiological eects in PCA.
Materials and methods
Chemicals and growth factors
All chemicals were obtained from Research Organics (Cleveland, OH), unless otherwise noted.
Recombinant human NDFb-1 (14 ± 246) represents the entire soluble extracellular domain of NDFb-1. Along with other NDF isoforms, it was supplied by Amgen, Inc. (Thousand Oaks, CA). Recombinant human TGF-a was obtained from GibcoBRL (Gaithersburg, MD).
Antibodies
Primary antibodies against phosphotyrosine, ErbB1/ EGFR, PI3-K, SHC, PLC-g1, STAT1, p70 S6K and mHOG/p38 were purchased from Upstate Biotechnology Incorporated (UBI; Lake Saranac, NY), ErbB2/NEU and ErbB3 from NeoMarkers (Freemont, CA), p85 from Transduction Laboratories, ERK1 and SAPK/JNK1 from Santa Cruz Biotechnology (Santa Cruz, CA), and actin from Sigma. HRP-conjugated anti-mouse antibody and rabbit anti-mouse IgG were obtained from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA), while HRP-conjugated anti-rabbit antibody was from Amersham (Arlington Heights, IL).
Cells, culture conditions and growth curves DU145, LNCaP, and PC-3 are human PCA lines derived from brain, lymph node, and bone metastases, respectively. They were obtained from the American Type Culture Collection (Rockville, MD). MLC-SV40 is an immortalized, non-transformed prostate epithelial line described previously . CWR22 is a serially transplantable xenograft of primary human PCA, which displays androgen-dependent growth and PSA secretion when passaged in nude mice (Wainstein et al., 1994) CWR22 can be maintained in cell culture for approximately 1 week.
All tissue culture media and supplements were obtained from GibcoBRL. DU145 and PC-3 were maintained in DMEM+10% FBS, LNCaP in RPMI 1640 +10% FBS, and CWR22 in MEMplus+2% FBS. MLC-SV40 was cultured in Keratinocyte Serum-Free Medium, supplemented with 50 mg/ mL bovine pituitary extract and 5 ng/mL recombinant human EGF. All growth media were supplemented with penicillin G, streptomycin, and amphotericin B (Fungizone).
For analysis of ErbB kinase family and NDF expression, cells were harvested at 70 ± 80% con¯uency.
NDF treatment
Prior to short-term NDF or TGF-a treatment, LNCaP was shifted overnight to serum-free DMEM. Cells were stimulated with 128 ng/mL (5 nM) NDFb-1 or 25 ng/mL (5 nM) TGF-a for 10 min at 378C. For prolonged growth factor treatment, 2610
5 LNCaP were plated out per 100 mm dish in RPMI 1640+10% FBS. After 24 h, plates were shifted to fresh RPMI 1640+10% FBS containing 12.8 ng/mL (0.5 nM) NDFb-1, 2.5 ng/mL TGF-a (0.5 nM), or no supplemented factors (Day 0). Every 2 days thereafter, the number of viable cells was determined by trypsinizing triplicate plates and counting the trypan blueexcluding cells in a hemocytometer. For those plates which were not counted, old media was replaced with fresh media. On Day 3, cells were photographed by phasecontrast microscopy.
RT ± PCR
Total RNA was extracted with Tri-Reagent (GibcoBRL (Wainstein et al., 1994) , and they yielded a product of 680 bp. The GAPDH primer sequences were (forward) 5'-ATCAAGAAGGTGGT-GAAGCAGG-3' and (backward) 5'-GCAACTGTGAG-GAGGGGAGATT-3', yielding a product of 360 bp. The EGF primer sequences were (forward) 5'-AACT-GCTTGGTGTTCGTGTCG-3' and (backward) 5'-TCGG-TGTTGATGCACTTGGAG-3', yielding a product of 393 bp. Thirty cycles of PCR were utilized: 948C for 30 s, 558C for 1 min, 728C for 1 min. PCR products were run on 2% agarose/ethidium bromide gels with 100 bp markers and visualized by u.v.
Immunoprecipitation and Western blotting
Cells were rinsed once in ice-cold PBS, then lysed in RIPA buer plus protease inhibitors and a tyrosine phosphatase inhibitor (50 mM Tris-Cl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 1 mM PMSF, 1 mg/mL pepstatin A, 0.2 U/mL aprotinin, 0.5 mg/mL leupeptin, 1 mM Na 3 VO 4 ) and cleared by centrifugation in a Beckman tabletop. The protein concentrations of lysates were determined with the Bio-Rad (Hercules, CA) D C detergent-compatible assay, using bovine serum albumin (BSA; Boehringer-Mannheim) as a standard. Immunoprecipitations were performed on 2 mg total cell protein. All lysates were pre-cleared with Protein A-Sepharose (Zymed, South San Francisco, CA), or Protein G-Sepharose, for EGFR IPs. For ERK1 and mHOG/p38 antibodies, 10 mL 10% SDS was added per 250 mL lysate, followed by boiling for 10 min. For each IP, 4 mg antibody was used, except for PLC-g1 IPs, in which 2 mg antibody was used. For all monoclonal antibodies, 4 mg of rabbit anti-mouse IgG was added to improve precipitation eciency. IPs were rocked overnight at 48C. Then, the immunocomplex was captured by adding Protein A-Sepharose, or Protein G-Sepharose for the EGFR IP, and rocked for an additional 2 h. Beads were washed 36 in RIPA, then boiled for 10 min in 80 mL 26SDS ± PAGE sample buer (125 mM Tris-Cl pH 6.8, 4% SDS, 2 mM EDTA, 20% glycerol, 0.6% bromphenol blue).
Half of each IP (40 mL) was loaded on a 7.5% or 9% SDS-polyacrylamide gel. Alternatively, for analysis of ErbB receptor and ligand expression, 50 mg of total cell protein was loaded per well. Kaleidoscope Prestained Standards (BioRad) or Prestained Protein Molecular Weight Standards, High Range (GibcoBRL) were also loaded. Proteins were transferred to PVDF membranes (Biotechnology Systems, Boston, MA) using a semi-dry apparatus (Pharmacia, Uppsala, Sweden). After blocking in BSA/TBST (20 mM Tris-Cl pH 7.6, 137 mM NaCl, 1% Tween-20, 5% BSA) for 1 h at RT, blots were incubated with primary antibody for 2 h at RT, washed 36 with TBST, incubated with HRPconjugated secondary antibody for 1 h, washed 36 with TBST, then developed by ECL (Amersham) and exposed to BioMax ®lm (Eastman Kodak, Rochester, NY).
JNK in vitro kinase assay
Serum-starved LNCaP were unstimulated or stimulated with 128 ng/mL (5 nM) NDFb-1, 25 ng/mL (5 nM) TGF-a, 10 mg/mL anisomycin, or 0.4 M sorbitol (Sigma). Growth factor treatments were for 10 min, while anisomycin and sorbitol treatments lasted 30 min at 378C. Lysates were prepared as above, and active JNK was precipitated from 2 mg cell protein with polyclonal anti-JNK (Santa Cruz). Complexes were captured with Protein A-Sepharose, followed by three washes of beads with RIPA buer, and one wash with kinase buer (50 mM Tris-Cl pH 8.0, 15 mM MgCl 2 , 1 mM DTT). Then, 0.5 mg bacterially-expressed GST-Jun and 10 mCi [g-32 P]ATP in 50 mL kinase buffer+100 mM cold ATP was added to each reaction, which proceeded for 30 min at 308C. Reactions were stopped by the addition of SDS ± PAGE sample buer and boiling for 10 min. Samples were loaded on a 10% SDS-polyacrylamide gel, run, dried, and exposed to X-OMAT ®lm (Eastman Kodak) with an intensifying screen at 7808C.
Mobility shift assays
The method of Yu was utilized to generate nuclear lysates and perform EMSAs (Yu et al., 1995) . Brie¯y, monolayer cultures of cells were rinsed once with PBS, once with PBS+1 mM Na 3 VO 4 +5 mM NaF, and once with hypotonic buer (20 mM HEPES pH 7.9, 1 mM EDTA, 1 mM EGTA, 1 mM Na 3 VO 4 , 20 mM NaF, 1 mM DTT, 0.5 mM PMSF, 1 mg/mL pepstatin A, 0.2 U/mL aprotinin, 0.5 mg/ mL leupeptin). Cells were scraped into hypotonic buer+0.2% NP-40 (USB, Cleveland, OH), then spun for 20 s at 15K r.p.m. in a cold-room microfuge. The supernatant was aspirated, the nuclei resuspended in highsalt buer (hypotonic buer+420 mM NaCl+20% glycerol) and rotated for 30 min at 48C. After spinning in a coldroom microfuge for 20 min, the supernatants (nuclear extracts) were removed, their protein concentration quantitated, then stored at 7808C.
The sequences of high-anity probes were 5'-AGCTT-CATTTCCCGTAAATCCCTAAAGCT-3' for the SIE oligo, and 5'-AGATTTCTAGGAATTCAATCC-3' for the b-casein probe. Probes were labeled with Klenow polymerase, [a-32 P]dCTP, and [a-32 P]dTTP. Hot probes (40 000 c.p.m./ reaction) were incubated with 3 mg MLC-SV40 or 12 mg LNCaP nuclear protein extracts in a solution containing 10 mM HEPES pH 7.9, 25 mM KCl, 0.5 mM EDTA, 5% glycerol, 0.5 mM DTT, 50 mg/mL poly(dI : dC) and 250 mg/ mL BSA. After incubation for 30 min at 308C, samples were run on a 0.256TBE/5% polyacrylamide non-denaturing gel. Gels were dried and exposed to BioMax or X-OMAT ®lm with an intensifying screen, at 7808C.
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